Altimmune (ALT) Non-Current Assets (2010 - 2026)
Altimmune's Non-Current Assets was $192.4 million in Q2 2026, compared with $1.93 million a year earlier.
Powered by 
Analysis
Altimmune (ALT) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Altimmune came in at $1.74 million, down 15.4% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of -34.9% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $2.05 million in FY2024 (+102.4%), $1.01 million in FY2023 (-92.8%), $14.12 million in FY2022 (-4.2%) and $14.74 million in FY2021 (-0.8%).
- The Q2 2026 figure marks the highest quarterly Non-Current Assets in data going back to Q4 2010.
- Compared with a year earlier, Non-Current Assets was higher in two of the last seven quarters, with growth averaging 9.1%.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2025 (growth of 137.4%); the worst was Q1 2024 (a decline of 94.0%).
- Per Business Quant data, ALT's Non-Current Assets in the three quarters before Q2 2026 was $954,000 (Q1 2026), $1.74 million (Q4 2025) and $1.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Altimmune | 411.69 Mn | -730.54 Mn | - | 192.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 192.40 Mn |
| Mar 31, 2026 | 954,000.00 |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.05 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 843,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 13.61 Mn |
| Jun 30, 2023 | 13.78 Mn |
| Mar 31, 2023 | 13.97 Mn |
| Dec 31, 2022 | 14.12 Mn |
| Sep 30, 2022 | 14.27 Mn |
| Jun 30, 2022 | 14.40 Mn |
| Mar 31, 2022 | 14.57 Mn |
| Dec 31, 2021 | 14.74 Mn |
| Sep 30, 2021 | 18.64 Mn |
API Access
Altimmune Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();